Don't have an account?
From screening to diagnosis to staging to monitoring, GE Healthcare offers solutions across the entire breast care pathway including Invenia ABUS 2.0, designed to detect cancer in dense breast tissue.
- Invenia ABUS 2.0
- LOGIQ E10 Series
- LOGIQ Fortis™
Invenia ABUS 2.0 for dense breasts
Clinical evidence is growing about the effectiveness of ultrasound for finding small, node-negative, invasive cancers that may be missed by mammography1. Patient-friendly Invenia™ ABUS 2.0 is the first FDA-approved ultrasound supplemental screening technology that is specifically designed for detecting cancer in dense breast tissue.
Designed for screening
Improve breast cancer detection by 35.7 percent over mammography alone.2
Remarkable image quality
Look differently at dense breast tissue with advanced interpretation tools
AI Assistant
Helps to detect and characterize breast lesions for clinical confidence
LOGIQ E10 Series Ultrasound
The LOGIQ™ E10 Series helps you make a real difference in the lives of patients with breast disease. The systems’ cSound™ Architecture provides images of excellent detail and contrast resolution for greater diagnostic confidence, while new AI-based workflow tools help increase exam efficiency.
AI decision support
Breast Assistant powered by Koios DS™ harnesses AI for clinical confidence
Advanced breast tools
Label, measure and describe lesions, nodules, and lymph nodes
Compare assistant
Compare a prior ultrasound, mammography, CT or MR image with current images
2D shear wave elastography
Quantiative measure of tissue elasticity shown in color-coded elastograms
LOGIQ Fortis™ Ultrasound
The GE LOGIQ Fortis™ ultrasound is built to help clinicians deliver on the promise of confident care in breast imaging. Small and sleek enough to move to patients throughout your facility and equipped with our most powerful technology, it is GE’s affordable all-in-one solution.
AI decision support
Breast Assistant powered by Koios DS™ harnesses AI for clinical confidence
Auto lesion segmentation
Saves keystrokes and provides consistency when measuring lesions
Measure assistant
Simple steps to assist the user with breast measurements
Breast productivity
Measurement package to make labeling, measuring and describing lesions easy
Personalized breast care with ultrasound
Screening; diagnosis and staging; treatment; and follow-up: Our breast ultrasound offerings feature excellent measurement and decision support tools to help you provide excellent care for your patients wherever they may be on the care pathway.
REFERENCES
- Mandelson et al. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 2000; 92:1081–1087.
- FDA PMA P110006 summary of safety and effectiveness
JB00245MEN May 2024